dipyridamole has been researched along with Extrasystole, Ventricular in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Virgilio, C | 1 |
Pak, S | 1 |
Arnell, T | 1 |
Donayre, C | 1 |
Lewis, RJ | 1 |
Stabile, BE | 1 |
White, R | 1 |
Rabin, DL | 1 |
Ali, A | 1 |
Barron, JT | 1 |
2 other studies available for dipyridamole and Extrasystole, Ventricular
Article | Year |
---|---|
Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary?
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Arter | 1996 |
Association of ventricular ectopy with nuclear scintigraphic perfusion defects during dipyridamole stress testing.
Topics: Aged; Dipyridamole; Electrocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Male | 1998 |